Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Sprt Regulatory News (SIS)

  • This share is currently suspended. It was suspended at a price of 33.50
  • There is currently no data for SIS

AGM Statement

25 Jun 2020 07:00

RNS Number : 9954Q
Science in Sport PLC
25 June 2020
 

 

 

25 June 2020

 

 

 

SCIENCE IN SPORT PLC

("Company" or "Group")

AGM Statement

 

Science in Sport plc (AIM: SIS), the premium performance nutrition company serving elite athletes, sports enthusiasts and the gym lifestyle community, announces the following statement from its Chairman, John Clarke, ahead of the Company's Annual General Meeting ("AGM") to be held this morning.

 

"As previously announced, the Company had conducted a number of scenario analyses which modelled the impact of COVID-19 on revenues for the current financial year and into 2021. Trading is currently in line with the base scenario developed as part of our contingency planning. As expected, retail sales in all markets remain adversely affected compared with normal levels. However, we are making very strong progress with our e-commerce business, with our own PhD and SiS platforms performing well, and our Amazon business outperforming. Pricing improvements and supply chain synergies are delivering an improved gross margin. This, together with planned COVID-19 cost cutting measures now implemented, is protecting our strong cash position.

 

"The Company's financial position remains robust given performance in line with our base scenario. The proceeds from the ÂŁ4.5 million placing in April 2020 means the Company has substantial headroom and can exit the current trading environment well placed to deliver on its long-term growth strategy. As a further contingency we put in place an ÂŁ8.0 million invoice financing debt facility, which remains unused.

 

"Despite the continued high degree of uncertainty from the COVID-19 pandemic and associated economic impact, our strategy remains unchanged, focusing on science-led innovation, building brand equity, taking our share of e-commerce business and developing global markets. We are confident that we are well prepared to deliver on this strategy and will provide further details on progress in our half year results announcement on 16 September 2020.

 

"On behalf of the Board, I would like to thank all employees of the Group for their commitment to the Company in the face of the challenges presented by the COVID-19 pandemic. As a result of their dedication and professionalism, we have continued to serve customers throughout the first half of the year without interruption."

 

For further information:

 

Science in Sport plc

Stephen Moon, Chief Executive Officer

James Simpson, Chief Financial Officer

+44 (0) 20 7400 3700

LiberumNominated adviser and broker

Bidhi BhomaJames GreenwoodWill Hall

+44 (0) 20 3100 2000

 

Notes to Editors

 

About Science in Sport plc

 

Science in Sport plc is a leading sports nutrition business that develops, manufactures and markets innovative nutrition products for professional athletes, sports and fitness enthusiasts and the gym lifestyle community. The Company has two highly regarded brands: PhD Nutrition, a premium protein brand targeting gym lifestyle and sports enthusiasts, and SiS, a leading brand among elite athletes and professional sports teams.

The two brands are sold internationally through multiple retail channels, both traditional and online, including major supermarkets and high street chains, specialist sports retailers and e-commerce sites including Amazon and the brands' own websites. They enable the Company to address the full breadth of the performance nutrition market currently estimated at approximately £10 billion worldwide.

PhD is one of the UK's leading protein brands with a reputation for high quality and product innovation. The brand has grown rapidly, based on its core protein powders, since launch in 2005. The range now comprises powders, bars, flapjacks, drinks and other products including the high protein, low sugar range, PhD Smart. PhD brand ambassadors include endurance athlete Ross Edgley, WBA international champion Jordan Gill, Team GB Olympic sprinter Asha Philip and leading fitness influencer Obi Vincent. The PhD brand is an official partner to the Tough Mudder Challenge and Race Series.

SiS, founded in 1992, has a core range comprising gels, powders and bars focused on energy, hydration and endurance. SiS is the official sports nutrition supplier to many professional teams and organisations including Team INEOS Cycling, Team Ineos UK (America's Cup Team), British Cycling, Cycling Australia, USA Cycling and USA Triathlon. SiS supplies more than 100 professional football clubs in the UK, Europe and USA, and is an official partner to the Rock 'n' Roll Marathon Series. SiS brand ambassadors include Olympians Sir Chris Hoy MBE, Mark Cavendish MBE and Adam Peaty MBE.

Science in Sport is headquartered in London. Its shares joined the AIM market of the London Stock Exchange in August 2013 and trade under the ticker symbol SIS.

For further information, please visit www.scienceinsport.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMSELFMLESSEDM
Date   Source Headline
29th Jul 202412:05 pmRNSTR-1: Notification of Major Holdings
29th Jul 202410:02 amRNSTR-1: Notification of Major Holdings
26th Jul 202411:52 amRNSTR-1: Notification of Major Holdings
24th Jul 202412:43 pmRNSResult of General Meeting and Total Voting Rights
16th Jul 202410:26 amRNSTR-1: Notification of Major Holdings
16th Jul 202410:11 amRNSTR-1: Notification of Major Holdings
16th Jul 202410:10 amRNSTR-1: Notification of Major Holdings
9th Jul 20249:20 amRNSDirector/PDMR Shareholding
8th Jul 20242:16 pmRNSDirector/PDMR Shareholding
8th Jul 20241:36 pmRNSPosting of Circular and notice of General Meeting
8th Jul 20247:00 amRNSResult of the Retail Offer
5th Jul 202412:38 pmRNSDirector/PDMR Shareholding
5th Jul 20247:01 amRNSManagement Incentive Plan
5th Jul 20247:00 amRNSResult of Placing and director dealings
4th Jul 20245:10 pmRNSRetail Offer for up to £0.5 million
4th Jul 20245:04 pmRNSProposed Placing and Retail Offer
1st Jul 20247:00 amRNSNominated Adviser and Broker
28th Jun 20243:42 pmRNSAnnual Report and Notice of Annual General Meeting
28th Jun 20247:00 amRNSFinal Results for the Year Ended 31 December 2023
28th Jun 20247:00 amRNSHalf Year Trading Update and Board Changes
12th Jun 20247:00 amRNSNotice of Results
21st May 20247:00 amRNSNotification of Major Holdings
20th May 20247:00 amRNSNotification of Major Holdings
20th May 20247:00 amRNSNotification of Major Holdings
15th May 202410:35 amRNSNotification of Major Holdings
14th May 202411:20 amRNSNotification of Major Holdings
6th Mar 20247:00 amRNSTrading Update
5th Jan 20247:00 amRNSDirector/PDMR Shareholding
5th Jan 20247:00 amRNSNotification of Major Holdings
29th Dec 202311:20 amRNSIssue of Equity and Total Voting Rights
19th Oct 20237:00 amRNSDirectorate Change
16th Oct 20237:00 amRNSBoard Changes
28th Sep 202310:30 amRNSInterim Results - Replacement
28th Sep 20237:00 amRNSAppointment of Non Exec Chairman
28th Sep 20237:00 amRNSInterim Results
28th Jul 20232:58 pmRNSResult of Annual General Meeting
28th Jul 20237:00 amRNSBoard changes
10th Jul 20237:00 amRNSDirector/PDMR Shareholding
5th Jul 20233:49 pmRNSTR-1: Notification of Major Holdings
5th Jul 20237:00 amRNSBoard Change and Notice of AGM
4th Jul 20237:30 amRNSRestoration - Science in Sport PLC
4th Jul 20237:00 amRNSRestoration of Trading & Posting of Annual Report
3rd Jul 20237:30 amRNSSuspension - Science In Sport Plc
3rd Jul 20237:00 amRNSTemporary Suspension
29th Jun 202310:38 amRNSReplacement RNS - Preliminary Results
29th Jun 20237:00 amRNSFinal results
28th Jun 202310:43 amRNSNotification of Major Holdings
23rd Jun 20237:00 amRNSNotice of Final Results
2nd May 20233:33 pmRNSAIM Rule 17 / Schedule 2(g) Update
18th Apr 20237:00 amRNSInvestor Site Visit

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.